Abstract:Family hypercholesterolemia (FH) is a genetic disorder caused by mutation in the low density lipoprotein receptor (LDLR) gene. It is characterized by a high concentration of low density lipoprotein (LDL), which frequently gives rise to tendon xanthenes and premature coronary artery disease. We studied a FH family ,which was diagnosed by clinical features and blood lipid tests. The Total cholesterol level of the family was 19.05 mmol/L and the LDL level was 17.06 mmol/L in the proband homozygous FH subjects, while the total cholesterol was 7.96 mmol/L and LDL was 5.55 mmol/L in the heterozygous FH subjects. DNA segments amplified with PCR were sequenced in heterozygous and homozygous FH patients. Two novel identical mutation alleles of GAG683GCG, which caused an amino acid change from Glu to Ala, were detected in Exon4 of LDL receptor gene in homozygous proband. DNA sequencing revealed that the proband's parents were heterozygotes with the same mutational alleles as the proband. These results are in coincidence with the clinical diagnoses. Moreover Epstein-Barr virus transformed lymphocytes (EBV-Ls) were derived by routine virus infection transforming protocol. The cells bounded with the fluorescently conjugated LDL were measured by fluorescence flow cytometry. The ratios of functional LDLR in EBV-Ls originated from homozygous FH, heterozygous FH and normal control were 7.02%, 62.64% and 84.69%, respectively. As a result, the homozygous FH patient's LDLR had 8.29% and the heterozygous FH patient's LDLR had 73.96% of the activity of the control. It is apparent that LDL receptor activity of homozygous FH subject is significantly lower than normal control. The data from fluorescence flow cytometry analysis of EBV-Ls strongly support the clinical diagnoses and the results of DNA sequencing. In accordance with the updated version of UMD-LDLR, the mutant GAG683GCG in Exon4 of LDLR gene which we have identified is a novel mutation of the LDLR gene in human with hypercholesterolemia.

[Genomic Structure of Low Density Lipoprotein Receptor Related Protein 5 Gene].

Association of LRP5/6 Gene Polymorphism and Hirschsprung's Disease

Polymorphisms of the low-density lipoprotein receptor-related protein 5 (LRP5) gene are associated with obesity phenotypes in a large family-based association study.

Identification of a Novel Mutation at the Point of Low Density Lipoprotein Receptor Gene from a Subject with Familial Hypercholesterolemia

GW24-e3589 A novel mutation 1587_1588 del2 of the low-density lipoprotein receptor gene associated with familial hypercholesterolemia in a Chinese family

Molecular cloning and characterization of a novel human gene containing 4 ankyrin repeat domains.

LRP5 Polymorphism-a Potential Predictor of the Clinical Outcome in Advanced Gastric Cancer Patients Treated with EOF Regimen.

LRP5, low-density-lipoprotein-receptor-related protein 5, is a determinant for bone mineral density

Molecular Analysis of X-linked Recessive Retinitis Pigmentosa

Sp1 and KLF15 Regulate Basal Transcription of the Human LRP5 Gene

Common polymorphism in the LRP5 gene may increase the risk of bone fracture and osteoporosis.

Association of Common Polymorphisms in the Lrp6 Gene with Sporadic Coronary Artery Disease in A Chinese Population

A New Player in Neurodevelopment and Brain Maturation

Genomic Structure Analysis of SNC6, a Progesterone-Receptor Associated Protein Gene, and Cloning and Characterization of Its 5′-Flanking Region

Structure Characterization of Human RalGDS Gene, and the Identification of Its Novel Variant.

Lrp6 Protein Regulates Low Density Lipoprotein (ldl) Receptor-Mediated Ldl Uptake

LDL Receptor-Related Protein 5 (LRP5) Affects Bone Accrual and Eye Development

Analysis on the Negative Regulatory Region of Mouse LRP5 Gene

Isolation, Tissue Distribution And Prokaryotic Expression Of A Novel Human X-Linked Gene Lhfpl1

Identification Of Two Novel Lrp5 Mutations In Families With Familial Exudative Vitreoretinopathy

Identification and Characterization of a Novel Gene (c4orf5) Located on Human Chromosome 4q with Specific Expression in Cardiac and Skeletal Muscle.